Sign in Subscribe

Drug Pricing

Timely insights into evolving drug pricing policies and reimbursement practices in China.
Oct
11
NHSA Insurance Funding Expert Zheng Jie: Shifting from Excessive Price Reduction to Value-Based Procurement for China's Drug Pricing Dilemma

NHSA Insurance Funding Expert Zheng Jie: Shifting from Excessive Price Reduction to Value-Based Procurement for China's Drug Pricing Dilemma

At the 5th China Rare Disease Cooperation and Exchange Conference, Zheng Jie, the leader of the Insurance Funding Analysis Expert
3 min read
Aug
02
China Implements More Moderate and Predictable Price Reduction for Older NRDL-Negotiated Drugs

China Implements More Moderate and Predictable Price Reduction for Older NRDL-Negotiated Drugs

In late June, the National Healthcare Security Administration (NHSA) commenced the 2023 National Reimbursement Drug List (NRDL) Dynamic Update, aiming
4 min read